Literature DB >> 26335243

Accuracy of preoperative diagnosis of lymph node metastasis for thoracic esophageal cancer patients from JCOG9907 trial.

Tomoya Yokota1, Hiroyasu Igaki2, Ken Kato3, Yasuhiro Tsubosa4, Junki Mizusawa5, Hiroshi Katayama5, Kenichi Nakamura5, Haruhiko Fukuda5, Yuko Kitagawa6.   

Abstract

BACKGROUND: Accurate clinical evaluation of lymph nodes is crucial for selection of the optimum treatment strategy for individual esophageal cancer patients. This study investigated the accuracy of preoperative clinical diagnosis of lymph node metastasis for patients with clinical stage II/III esophageal squamous cell carcinoma.
METHODS: Patients assigned to receive surgery and postoperative chemotherapy in JCOG9907 trial were studied to evaluate the concordance between clinical and pathological nodes. Preoperative diagnosis was based on computed tomography or magnetic resonance imaging.
RESULTS: Among 166 patients in the postoperative group, 160 with sufficient pathological data were studied. The patient background characteristics were: male/female, 147/13; median age, 61 years (range 39-75 years); primary tumor site (upper/middle/lower), 15/76/69; cN0/cN1, 53/107. The sensitivity and specificity of clinical nodes for diagnosis of pathological nodes were 72.7 and 51.3 %, respectively; the positive and negative predictive values were 82.2 and 37.7 %, respectively. The lymph nodes overestimated in the preoperative diagnosis included thoracic paratracheal lymph nodes (#106) (n = 8), middle thoracic paraesophageal lymph nodes (#108) (n = 4), lymph nodes along the lesser curvature (#3) (n = 4), right cardiac lymph nodes (#1) (n = 3), and left cardiac lymph nodes (#2) (n = 2).
CONCLUSION: Diagnosis of clinical nodes has low specificity and low negative predictive value for prediction of pathological node category in the preoperative diagnosis of lymph node metastasis for patients with locally advanced resectable esophageal cancer. Clinical staging techniques must therefore be improved for accurate preoperative diagnosis.

Entities:  

Keywords:  Clinical diagnosis; Esophageal squamous cell carcinoma; Lymph nodes; Pathological diagnosis

Mesh:

Year:  2015        PMID: 26335243     DOI: 10.1007/s10147-015-0899-z

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  21 in total

1.  Surgical treatment of advanced carcinoma of the esophagus.

Authors:  S Abe; M Tachibana; T Shimokawa; M Shiraishi; T Nakamura
Journal:  Surg Gynecol Obstet       Date:  1989-02

2.  Evaluation of the accuracy of preoperative staging in thoracic esophageal cancer.

Authors:  T Nishimaki; O Tanaka; N Ando; H Ide; H Watanabe; M Shinoda; W Takiyama; H Yamana; K Ishida; K Isono; M Endo; T Ikeuchi; T Mitomi; H Koizumi; M Imamura; T Iizuka
Journal:  Ann Thorac Surg       Date:  1999-12       Impact factor: 4.330

3.  Prognostic Factors in Patients Receiving Neoadjuvant 5-Fluorouracil plus Cisplatin for Advanced Esophageal Cancer (JCOG9907).

Authors:  Tomoya Yokota; Nobutoshi Ando; Hiroyasu Igaki; Masayuki Shinoda; Ken Kato; Junki Mizusawa; Hiroshi Katayama; Kenichi Nakamura; Haruhiko Fukuda; Yuko Kitagawa
Journal:  Oncology       Date:  2015-04-16       Impact factor: 2.935

4.  Computed tomographic evaluation of esophageal carcinoma.

Authors:  R A Halvorsen; W M Thompson
Journal:  Semin Oncol       Date:  1984-06       Impact factor: 4.929

5.  Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

Authors:  Katrin M Sjoquist; Bryan H Burmeister; B Mark Smithers; John R Zalcberg; R John Simes; Andrew Barbour; Val Gebski
Journal:  Lancet Oncol       Date:  2011-06-16       Impact factor: 41.316

6.  A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907).

Authors:  Nobutoshi Ando; Hoichi Kato; Hiroyasu Igaki; Masayuki Shinoda; Soji Ozawa; Hideaki Shimizu; Tsutomu Nakamura; Hiroshi Yabusaki; Norio Aoyama; Akira Kurita; Kenichiro Ikeda; Tatsuo Kanda; Toshimasa Tsujinaka; Kenichi Nakamura; Haruhiko Fukuda
Journal:  Ann Surg Oncol       Date:  2011-08-31       Impact factor: 5.344

7.  Submucosal territory of the direct lymphatic drainage system to the thoracic duct in the human esophagus.

Authors:  Kenshi Kuge; Gen Murakami; Shunji Mizobuchi; Yoichi Hata; Takashi Aikou; Shiro Sasaguri
Journal:  J Thorac Cardiovasc Surg       Date:  2003-06       Impact factor: 5.209

Review 8.  Staging of squamous esophageal cancer: accuracy and value.

Authors:  A H Hölscher; H J Dittler; J R Siewert
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

9.  Patterns of lymphatic spread in thoracic esophageal cancer.

Authors:  T Nishimaki; O Tanaka; T Suzuki; K Aizawa; K Hatakeyama; T Muto
Journal:  Cancer       Date:  1994-07-01       Impact factor: 6.860

10.  Staging investigations for oesophageal cancer: a meta-analysis.

Authors:  E P M van Vliet; M H Heijenbrok-Kal; M G M Hunink; E J Kuipers; P D Siersema
Journal:  Br J Cancer       Date:  2008-01-22       Impact factor: 7.640

View more
  15 in total

1.  Preoperative lymph node status on computed tomography influences the survival of pT1b, T2 and T3 esophageal squamous cell carcinoma.

Authors:  Kotaro Sugawara; Hiroharu Yamashita; Yukari Uemura; Koichi Yagi; Masato Nishida; Susumu Aikou; Sachiyo Nomura; Yasuyuki Seto
Journal:  Surg Today       Date:  2018-11-23       Impact factor: 2.549

2.  Pattern of lymph node metastasis in thoracic esophageal squamous cell carcinoma with poor differentiation.

Authors:  Jinling Zhang; Yuanyuan Liu; Fengyuan Che; Yi Luo; Wei Huang; Xueyuan Heng; Baosheng Li
Journal:  Mol Clin Oncol       Date:  2018-04-13

Review 3.  Comparison of two major staging systems of esophageal cancer-toward more practical common scale for tumor staging.

Authors:  Harushi Udagawa; Masaki Ueno
Journal:  Ann Transl Med       Date:  2018-02

4.  Impact of CT-assessed changes in tumor size after neoadjuvant chemotherapy on pathological response and survival of patients with esophageal squamous cell carcinoma.

Authors:  Sohei Matsumoto; Kohei Wakatsuki; Hiroshi Nakade; Tomohiro Kunishige; Shintaro Miyao; Akinori Tsujimoto; Takanari Tatsumi; Masayuki Sho
Journal:  Langenbecks Arch Surg       Date:  2022-01-06       Impact factor: 3.445

5.  Feasibility study of adjuvant chemotherapy with S-1 after curative esophagectomy following neoadjuvant chemotherapy for esophageal cancer.

Authors:  Noriyuki Hirahara; Takeshi Matsubara; Shunsuke Kaji; Hikota Hayashi; Koki Kawakami; Yohei Sasaki; Satoshi Takao; Natsuko Takao; Ryoji Hyakudomi; Tetsu Yamamoto; Yoshitsugu Tajima
Journal:  BMC Cancer       Date:  2022-06-30       Impact factor: 4.638

6.  Clinical evaluation of right recurrent laryngeal nerve nodes in thoracic esophageal squamous cell carcinoma.

Authors:  Zhen-Xuan Li; Xiao-Dong Li; Xian-Ben Liu; Wen-Qun Xing; Hai-Bo Sun; Zong-Fei Wang; Rui-Xiang Zhang; Yin Li
Journal:  J Thorac Dis       Date:  2020-07       Impact factor: 2.895

7.  Evaluation of subcarinal lymph node dissection and metastasis in transmediastinal radical esophagectomy.

Authors:  Jun Shibamoto; Hitoshi Fujiwara; Hirotaka Konishi; Atsushi Shiozaki; Takuma Ohashi; Takeshi Kubota; Hiroki Shimizu; Tomohiro Arita; Yusuke Yamamoto; Ryo Morimura; Yoshiaki Kuriu; Hisashi Ikoma; Kazuma Okamoto; Eigo Otsuji
Journal:  Esophagus       Date:  2021-02-18       Impact factor: 4.230

8.  Support Vector Machines Model of Computed Tomography for Assessing Lymph Node Metastasis in Esophageal Cancer with Neoadjuvant Chemotherapy.

Authors:  Zhi-Long Wang; Zhi-Guo Zhou; Ying Chen; Xiao-Ting Li; Ying-Shi Sun
Journal:  J Comput Assist Tomogr       Date:  2017 May/Jun       Impact factor: 1.826

9.  Contrast-enhanced computed tomography combined with Chitosan-Fe3O4 nanoparticles targeting fibroblast growth factor receptor and vascular endothelial growth factor receptor in the screening of early esophageal cancer.

Authors:  Juanjuan Gai; Zhenli Gao; Liqiang Song; Yongyun Xu; Weixin Liu; Chuanxin Zhao
Journal:  Exp Ther Med       Date:  2018-04-23       Impact factor: 2.447

Review 10.  Tissue clearing to examine tumour complexity in three dimensions.

Authors:  Jorge Almagro; Hendrik A Messal; May Zaw Thin; Jacco van Rheenen; Axel Behrens
Journal:  Nat Rev Cancer       Date:  2021-07-30       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.